The Case of UiPath (PATH)
UiPath (NYSE: PATH) continues to maintain one of the largest short positions in the technology sector, with approximately 29.3% of its float sold short. This high level of bearish positioning stands in contrast to recent improvements in the company's fundamental health score, which has risen significantly quarter-over-quarter.
Assessing the Squeeze Risk
While 29.3% is a high short interest figure, analysts note that the stock maintains sufficient average daily trading volume to allow for a relatively orderly exit for short sellers compared to lower-volume names. This reduces the immediate structural risk of a violent short squeeze, suggesting that current shorts may be holding long-term, fundamental views rather than purely speculative positions.
Key Takeaways
- Short Interest: 29.3% of float.
- Fundamentals: Strong improvement in quarterly health scores, yet the high short interest remains.
- Squeeze Pressure: Lower than expected due to high average daily volume, facilitating liquidity for shorts.
The Bottom Line
PATH represents a battleground stock where institutional shorts are pitted against improving fundamental metrics. The high short interest indicates that the market remains skeptical, but the liquidity of the shares may prevent a rapid squeeze.
Signal data sourced from fffinstill. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.